Processa Pharmaceuticals PCSA
NASDAQ PCSA
$1.87 -0.08 (-4.10%)
At close: Nov 10, 2026 · 4:00 PM EST

Processa Pharmaceuticals (PCSA) Return on Equity [ROE] (2013 - 2026)

Updated

Processa Pharmaceuticals' Return on Equity [ROE] was -1160.68% in Q2 2026, down 897.72 percentage points from -262.96% a year earlier and down 802.99 percentage points from the prior quarter.

Analysis

Processa Pharmaceuticals (PCSA) Return on Equity [ROE] (2013 - 2026) Analysis & Trends

For FY2025, Return on Equity [ROE] at Processa Pharmaceuticals came in at -372.97%, down 18.46 percentage points from FY2024.

  • Return on Equity [ROE] has now declined for four consecutive years, with a five-year change of -279.83 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Equity [ROE] was -354.51% in FY2024 (-175.99 pp), -178.52% in FY2023 (-12.09 pp), -166.43% in FY2022 (-119.23 pp) and -47.20% in FY2021 (+45.94 pp).
  • The Q2 2026 figure marks the lowest quarterly Return on Equity [ROE] since Q3 2014.
  • Compared with a year earlier, Return on Equity [ROE] was higher in four of the last eight quarters, with an average year-over-year change of -155.58 percentage points.
  • The best year-over-year quarter for Return on Equity [ROE] over five years was Q4 2025 (a gain of 190.14 percentage points); the worst was Q2 2026 (a drop of 897.72 percentage points).
  • Per Business Quant data, PCSA's Return on Equity [ROE] in the three quarters before Q2 2026 was -357.68% (Q1 2026), -244.96% (Q4 2025) and -213.90% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Processa Pharmaceuticals 5.22 Mn -8.52 Mn - -1,160.68%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,160.68%
Mar 31, 2026 -357.68%
Dec 31, 2025 -244.96%
Sep 30, 2025 -213.90%
Jun 30, 2025 -262.96%
Mar 31, 2025 -449.03%
Dec 31, 2024 -435.09%
Sep 30, 2024 -239.99%
Jun 30, 2024 -139.40%
Mar 31, 2024 -144.06%
Dec 31, 2023 -182.96%
Sep 30, 2023 -266.16%
Jun 30, 2023 -264.69%
Mar 31, 2023 -317.49%
Dec 31, 2022 -219.86%
Sep 30, 2022 -92.90%
Jun 30, 2022 -66.60%
Mar 31, 2022 -51.54%
Dec 31, 2021 -43.37%
Sep 30, 2021 -63.70%
API Access

Processa Pharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PCSA&period=max&api_key=YOUR_API_KEY